1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc.

BDTX
Black Diamond Therapeutics, Inc.US flagNASDAQ Global Select
2.02
USD
- -
- -
115.75MMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
70
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
70
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
-70
- Operating Expenses
4
9
29
70
127
93
86
79
50
+ Selling, General & Admin
1
2
8
21
30
28
27
27
17
+ Research & Development
3
7
22
48
97
64
59
51
34
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-4
-9
-29
-70
-127
-93
-86
-79
20
- Non-Operating (Income) Loss
- -
- -
6
-2
-1
-2
-4
-9
-2
+ Interest Expense, Net
- -
- -
- -
-4
-3
-2
-2
-2
-4
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
4
3
2
2
2
4
+ Other Non-Op (Income) Loss
- -
- -
6
2
2
- -
-2
-7
2
Pretax Income
-5
-9
-35
-67
-126
-91
-82
-70
22
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-5
-9
-35
-67
-126
-91
-82
-70
22
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-5
-9
-35
-67
-126
-91
-82
-70
22
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-5
-9
-35
-67
-126
-91
-82
-70
22
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-5
-9
-35
-67
-126
-91
-82
-70
22
EBIT
-4
-9
-29
-70
-127
-93
-86
-79
20
EBITDA
-4
-9
-29
-70
-127
-92
-86
-78
20
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
28.85
EBITA
-4
-9
-29
-70
-127
-93
-86
-79
20
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
100
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
28.39
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
31.95
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
1
- -
- -
- -
Basic Weighted Avg Shares
7
14
33
33
36
36
44
55
57
Basic EPS, GAAP
-0.64
-0.64
-1.08
-2.04
-3.47
-2.52
-1.88
-1.27
0.39
Basic EPS from Cont Ops
-0.64
-0.64
-1.08
-2.04
-3.47
-2.52
-1.88
-1.27
0.39
Diluted Weighted Avg Shares
7
14
33
33
36
36
44
55
58
Diluted EPS, GAAP
-0.64
-0.64
-1.08
-2.04
-3.47
-2.52
-1.88
-1.27
0.39
Diluted EPS from Cont Ops
-0.64
-0.64
-1.08
-2.04
-3.47
-2.52
-1.88
-1.27
0.39

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
8
52
156
320
216
128
134
101
132
+ Cash, Cash Equivalents & STI
8
52
155
315
210
123
131
99
129
+ Cash & Cash Equivalents
8
52
155
35
66
34
56
36
21
+ ST Investments
- -
- -
- -
280
144
88
75
62
108
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
4
6
5
3
3
4
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
3
10
32
29
25
21
11
+ Property, Plant & Equip, Net
- -
- -
- -
9
31
27
24
20
10
+ Property, Plant & Equip
- -
- -
- -
9
31
28
25
22
11
- Accumulated Depreciation
- -
- -
- -
- -
- -
1
1
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
2
1
1
1
1
1
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
2
1
1
1
1
1
1
Total Assets
8
52
158
330
248
156
159
123
143
+ Payables & Accruals
2
3
5
13
23
12
17
17
12
+ Accounts Payable
- -
- -
2
3
4
2
2
4
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
3
11
19
11
14
13
11
+ ST Debt
- -
- -
- -
1
- -
3
3
3
4
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
1
- -
3
3
3
4
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
2
3
5
14
24
15
20
21
16
+ LT Debt
- -
- -
- -
8
28
25
22
19
15
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
8
28
25
22
19
15
+ Other LT Liabilities
12
65
201
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
12
65
201
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
12
65
201
8
28
25
22
19
15
Total Liabilities
15
67
205
22
52
41
42
39
31
+ Preferred Equity and Hybrid Capital
12
61
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
4
425
440
453
534
570
577
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
4
425
440
453
534
570
577
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-7
-16
-51
-118
-244
-335
-417
-487
-465
+ Other Equity
- -
- -
- -
1
- -
-2
- -
- -
- -
Equity Before Minority Interest
-7
-16
-47
308
196
116
117
83
112
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-7
-16
-47
308
196
116
117
83
112
Total Liabilities & Equity
8
52
158
330
248
156
159
123
143
Shares Outstanding
33
33
33
36
36
36
52
57
57
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
9
28
28
25
22
19
Net Debt
-8
-52
-155
-35
-66
-34
-56
-36
-21
Net Debt to Equity
118.02
332.39
327.98
-11.24
-33.59
-29.66
-48.16
-43.75
-18.71
Tangible Common Equity Ratio
-238.54
-147.25
-29.79
93.35
79.09
74.04
73.62
67.91
78.46
Current Ratio
3.55
20.07
32.02
22.48
9.12
8.37
6.82
4.92
8.42
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-5
-9
-35
-67
-126
-91
-82
-70
22
+ Depreciation & Amortization
- -
- -
- -
- -
- -
1
- -
- -
- -
+ Non-Cash Items
- -
- -
10
10
18
15
12
10
16
+ Stock-Based Compensation
- -
- -
4
8
14
12
10
11
7
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
6
2
4
3
2
-1
9
+ Chg in Non-Cash Work Cap
2
- -
- -
5
7
-10
4
-3
-9
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
-3
-2
1
2
- -
- -
+ Inc (Dec) in Accts Payable
2
- -
2
9
10
-8
5
1
-5
+ Inc (Dec) in Other
- -
- -
- -
-1
-2
-3
-3
-4
-4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-2
-8
-25
-52
-100
-85
-67
-62
30
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
-3
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
-3
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
214
- -
- -
72
24
- -
+ Increase in Capital Stock
- -
- -
- -
214
- -
- -
72
24
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
-282
133
54
16
17
-45
+ Dec in LT Investment
- -
- -
- -
91
183
114
78
140
119
+ Inc in LT Investment
- -
- -
- -
-372
-50
-60
-62
-123
-164
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-282
131
53
16
17
-45
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
10
52
128
1
1
- -
- -
1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
10
52
128
215
1
- -
72
26
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
8
44
103
-119
31
-32
22
-20
-15
EBITDA
-4
-9
-29
-70
-127
-92
-86
-78
20
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
28.85
Free Cash Flow
-2
-9
-25
-52
-103
-85
-67
-62
30
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
30
Free Cash Flow to Equity
- -
40
-85
-52
-103
-85
-67
-62
30
Free Cash Flow per Basic Share
-0.34
-0.61
-0.76
-1.59
-2.84
-2.35
-1.52
-1.13
0.52
Price/Free Cash Flow
- -
- -
- -
-20.28
-1.98
-0.77
-1.85
-1.89
4.72
Cash Flow to Net Income
0.51
0.95
0.7
0.78
0.8
0.93
0.81
0.89
1.32
Capital Expenditures
- -
- -
- -
- -
-3
- -
- -
- -
- -